183 related articles for article (PubMed ID: 27557876)
21. Predicting Major Bleeding in Ischemic Stroke Patients With Atrial Fibrillation.
Hilkens NA; Algra A; Greving JP
Stroke; 2017 Nov; 48(11):3142-3144. PubMed ID: 28931618
[TBL] [Abstract][Full Text] [Related]
22. Performance of the HAS-BLED, ORBIT, and ATRIA Bleeding Risk Scores on a Cohort of 399 344 Hospitalized Patients With Atrial Fibrillation and Cancer: Data From the French National Hospital Discharge Database.
Pastori D; Marang A; Bisson A; Herbert J; Lip GYH; Fauchier L
J Am Heart Assoc; 2022 Dec; 11(23):e026388. PubMed ID: 36444864
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial.
Apostolakis S; Lane DA; Buller H; Lip GY
Thromb Haemost; 2013 Nov; 110(5):1074-9. PubMed ID: 24048467
[TBL] [Abstract][Full Text] [Related]
24. Composite risk scores and composite endpoints in the risk prediction of outcomes in anticoagulated patients with atrial fibrillation. The Loire Valley Atrial Fibrillation Project.
Banerjee A; Fauchier L; Bernard-Brunet A; Clementy N; Lip GY
Thromb Haemost; 2014 Mar; 111(3):549-56. PubMed ID: 24452108
[TBL] [Abstract][Full Text] [Related]
25. Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation.
Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Lip GYH; Marín F
Sci Rep; 2017 Sep; 7(1):12066. PubMed ID: 28935868
[TBL] [Abstract][Full Text] [Related]
26. Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors.
Chao TF; Lip GYH; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Chen SA
Thromb Haemost; 2018 Apr; 118(4):768-777. PubMed ID: 29510426
[TBL] [Abstract][Full Text] [Related]
27. Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial.
Esteve-Pastor MA; Rivera-Caravaca JM; Shantsila A; Roldán V; Lip GYH; Marín F
Thromb Haemost; 2017 Dec; 117(12):2261-2266. PubMed ID: 29212113
[TBL] [Abstract][Full Text] [Related]
28. The predictive ability of the CHADS2 and CHA2DS2-VASc scores for bleeding risk in atrial fibrillation: the MAQI(2) experience.
Barnes GD; Gu X; Haymart B; Kline-Rogers E; Almany S; Kozlowski J; Besley D; Krol GD; Froehlich JB; Kaatz S
Thromb Res; 2014 Aug; 134(2):294-9. PubMed ID: 24929840
[TBL] [Abstract][Full Text] [Related]
29. [Predictive value of four score systems on the bleeding risk in atrial fibrillation patients treated with dabigatran].
Ding CC; Zhan BM; Zhou W; Li MH; Hu LH; Bao HH; Cheng XS
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):748-752. PubMed ID: 32957757
[No Abstract] [Full Text] [Related]
30. The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion.
García-Fernández A; Marín F; Roldán V; Galcerá-Jornet E; Martínez-Martínez JG; Valdés M; Sogorb F; Lip GY
Int J Cardiol; 2016 Aug; 217():42-8. PubMed ID: 27179207
[TBL] [Abstract][Full Text] [Related]
31. Comparison of HAS-BLED and HAS-BED Versus CHADS
Poli D; Antonucci E; Pengo V; Testa S; Palareti G
Am J Cardiol; 2017 Apr; 119(7):1012-1016. PubMed ID: 28237286
[TBL] [Abstract][Full Text] [Related]
32. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.
Lip GY; Frison L; Halperin JL; Lane DA
J Am Coll Cardiol; 2011 Jan; 57(2):173-80. PubMed ID: 21111555
[TBL] [Abstract][Full Text] [Related]
33. Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients?
Esteve-Pastor MA; García-Fernández A; Macías M; Sogorb F; Valdés M; Roldán V; Muñiz J; Badimon L; Roldán I; Bertomeu-Martínez V; Cequier Á; Lip GY; Anguita M; Marín F;
Circ J; 2016 Sep; 80(10):2102-8. PubMed ID: 27557850
[TBL] [Abstract][Full Text] [Related]
34. How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
Steinberg BA; Shrader P; Kim S; Thomas L; Fonarow GC; Ansell J; Kowey PR; Singer DE; Gersh BJ; Mahaffey KW; Peterson ED; Piccini JP;
Am Heart J; 2016 Nov; 181():145-152. PubMed ID: 27823686
[TBL] [Abstract][Full Text] [Related]
35. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
[TBL] [Abstract][Full Text] [Related]
36. Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy.
Capodanno D; Rossini R; Musumeci G; Lettieri C; Senni M; Valsecchi O; Angiolillo DJ; Lip GY
Int J Cardiol; 2015 Nov; 199():319-25. PubMed ID: 26241637
[TBL] [Abstract][Full Text] [Related]
37. Comparison of HAS-BLED with other risk models for predicting the bleeding risk in anticoagulated patients with atrial fibrillation: A PRISMA-compliant article.
Zeng J; Yu P; Cui W; Wang X; Ma J; Zeng C
Medicine (Baltimore); 2020 Jun; 99(25):e20782. PubMed ID: 32569222
[TBL] [Abstract][Full Text] [Related]
38. Comparative validation of HAS-BLED, GARFIELD-AF and ORBIT bleeding risk scores in Asian people with atrial fibrillation treated with oral anticoagulant: A report from the COOL-AF registry.
Chichareon P; Winijkul A; Lip GYH; Krittayaphong R
Br J Clin Pharmacol; 2023 Aug; 89(8):2472-2482. PubMed ID: 36942465
[TBL] [Abstract][Full Text] [Related]
39. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.
Hijazi Z; Oldgren J; Lindbäck J; Alexander JH; Connolly SJ; Eikelboom JW; Ezekowitz MD; Held C; Hylek EM; Lopes RD; Siegbahn A; Yusuf S; Granger CB; Wallentin L;
Lancet; 2016 Jun; 387(10035):2302-2311. PubMed ID: 27056738
[TBL] [Abstract][Full Text] [Related]
40. Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation: Methodological issues of prediction models.
Sani M; Ayubi E; Mansori K; Khazaei S
Int J Cardiol; 2016 Nov; 222():949. PubMed ID: 27526365
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
